Home News

First competition payments in global Brucellosis Vaccine Prize competition

Prizes awarded to three organisations at the midway point of Phase 1 EDINBURGH, UK, July 6, 2017 – Three organisations have each been awarded prizes of US $100,000 following their initial application to the Brucellosis Vaccine Prize – a global US $30 million competition aimed at incentivising the development of a new Brucella melitensis vaccine. […]

AgResults’ US $30 million Brucellosis Vaccine Prize on the agenda at Global Sheep Veterinary Congress

        Release date: 24 May 2017 EDINBURGH, UK, May 24, 2017 – Small ruminant experts attending this month’s International Sheep Veterinary Congress in Harrogate are being encouraged to enter a US $30 million prize competition to develop a brucellosis vaccine to improve the livelihoods of smallholder farmers in developing countries. The Brucellosis […]

OIE & GALVmed team up to promote harmonised registration of veterinary drugs in the SADC region

(Johannesburg, 11 May 2017) In a globalising world where clusters of countries increasingly face the same challenges and seek closer cooperation to deal with these issues together, great gains can be made by harmonising approaches to problem solving and avoiding duplication of efforts among countries in the same region. One such area is the registration of […]

ViroVet and GALVmed to collaborate on novel vaccines for sheep & goats

LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a collaboration with GALVmed. Under the collaboration, ViroVet will extend its vaccine pipeline to include novel vaccines for small ruminants. Since its capital increase in December […]

Researchers on a mission to improve the East Coast Fever vaccine

(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM)  was developed in mid-70s and since then new tools have been developed   to characterise the vaccine strains/stocks and provide new knowledge […]

Applications now open for AgResults’ Global US $30 Million Brucellosis Vaccine Prize

FOR IMMEDIATE RELEASE November 18, 2016 Press Office: +44 (0)20 8647 4467 Email: nic.daley@garnettkeeler.com Additional press contacts below   Competition aims to incentivize vaccine development breakthrough EDINBURGH, UK, November 18, 2016 – A US $30 million prize competition to develop a brucellosis vaccine to improve the livelihoods of smallholder farmers in developing countries is now […]

New GALVmed report on requirements, processes to register veterinary products in Africa & South Asia

As part of GALVmed’s regulatory harmonisation efforts, a new document was developed to provide a summarised overview of the country requirements and procedures needed to register veterinary products in 30 African and South Asian countries. Registering veterinary medicines through the current processes is cumbersome, often unpredictable and time consuming. The new report is a resource […]

New blood test developed to tackle major livestock disease in Africa

(9th September 2016) The University of Dundee and the Global Alliance for Livestock Veterinary Medicines (GALVmed) have partnered to develop a simple and effective device that tests for a cattle disease that is endemic in 40 African countries and accounts for up to a 50 percent loss in milk and meat production in the continent. The […]

First ever licensed vaccine against major cause of epilepsy in developing world

Vaccine will protect against the fourth highest foodborne hazard ranked by WHO, which causes approximately 30% of epilepsy cases in humans in the developing world. (20/07/2016) – An innovative vaccine technology developed by Professor Marshall Lightowlers at the University of Melbourne has become the first licensed vaccine for the zoonotic pig disease porcine cysticercosis. Neurocysticercosis […]

US $30 million prize launched to develop a B. melitensis vaccine

GALVmed and AgResults are delighted to announce the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to develop a vaccine against brucellosis to be used mainly in developing countries. The prize – one of the largest of its kind – is funded by AgResults, a […]

1 2 3 18